---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-097897"
form_type: "8-K"
ticker: "CLB"
cik: "0001958086"
company_name: "Core Laboratories Inc. /DE/"
filed_at: "2025-07-23T23:59:59+00:00"
generated_at: "2026-05-18T03:42:07.290024+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Core Lab Q2 rev $130.2M (+5% seq, flat YoY); ex-items EPS $0.19; free cash flow $10.4M

## Summary
- Q2 revenue $130.2M (+5% sequentially, flat YoY); GAAP EPS $0.22; ex-items EPS $0.19 (-14% YoY, +33% sequentially).
- Ex-items operating income $14.5M, margins 11% (+160 bps seq); incremental margins 41%.
- Free cash flow $10.4M (+160% seq); net debt reduced $9.1M; leverage ratio improved to 1.27x.
- Company repurchased 237,632 shares for $2.7M in Q2.
- Credit facility amended: commitments raised to $150M from $135M, maturity extended to July 2029, $50M accordion.

## SEC filing metadata
- accession: 0000950170-25-097897
- form_type: 8-K
- ticker: CLB
- cik: 0001958086
- company_name: Core Laboratories Inc. /DE/
- filed_at: 2025-07-23T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.02, 2.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1958086/000095017025097897/0000950170-25-097897-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1958086/000095017025097897/clb-20250722.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-097897
- JSON: https://secwatch.observer/filing/0000950170-25-097897.json
- Plain text: https://secwatch.observer/filing/0000950170-25-097897.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.